AASTOCKS Financial News

HSI¹	24,040.34	+68.05	98.10B
HSCEI¹	8,051.67	+21.13	24.86B

Back Zoom + Zoom - Block Traded

SIHUAN PHARM (00460.HK)'s Skin Booster Injection Obtains Approval for Launch of Additional Specifications
2026-10-05 17:28:51
SIHUAN PHARM (00460.HK) announced that five additional specifications of the sodium hyaluronate compound solution for injection (skin booster injection), commercially named Dong Yan, independently developed by its Meiyan Space unit, have officially obtained approval for launch from the National Medical Products Administration. (ha/u)~

AASTOCKS Financial News
Website: www.aastocks.com

This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

(1) HK Indices are real time

Home|RT Quote|Market|News|Indices
Feedback

View: Mobile|Desktop
Lang: 繁|简|EN

Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.